Publication: Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients.
dc.contributor.author | Gonzalez-Serna, Alejandro | |
dc.contributor.author | Genebat, Miguel | |
dc.contributor.author | Ruiz-Mateos, Ezequiel | |
dc.contributor.author | Leal, Manuel | |
dc.date.accessioned | 2023-01-25T08:30:52Z | |
dc.date.available | 2023-01-25T08:30:52Z | |
dc.date.issued | 2016-01-18 | |
dc.identifier.doi | 10.2147/DDDT.S100639 | |
dc.identifier.essn | 1177-8881 | |
dc.identifier.pmc | PMC4723024 | |
dc.identifier.pmid | 26848259 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723024/pdf | |
dc.identifier.unpaywallURL | https://www.dovepress.com/getfile.php?fileID=28659 | |
dc.identifier.uri | http://hdl.handle.net/10668/9810 | |
dc.journal.title | Drug design, development and therapy | |
dc.journal.titleabbreviation | Drug Des Devel Ther | |
dc.language.iso | en | |
dc.organization | Instituto de Biomedicina de Sevilla-IBIS | |
dc.page.number | 353-4 | |
dc.pubmedtype | Letter | |
dc.pubmedtype | Research Support, Non-U.S. Gov't | |
dc.pubmedtype | Comment | |
dc.rights | Attribution-NonCommercial 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | |
dc.subject.mesh | Animals | |
dc.subject.mesh | CCR5 Receptor Antagonists | |
dc.subject.mesh | Cyclohexanes | |
dc.subject.mesh | HIV Fusion Inhibitors | |
dc.subject.mesh | HIV Infections | |
dc.subject.mesh | HIV-1 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Triazoles | |
dc.title | Short-term maraviroc exposure, a clinical approach to decide on maraviroc prescription in HIV-1-infected treatment-naïve patients. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 10 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1